Trials / Active Not Recruiting
Active Not RecruitingNCT03251118
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 15,000 (estimated)
- Sponsor
- Target PharmaSolutions, Inc. · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
TARGET-IBD is a 5-year, longitudinal, observational study of adult and pediatric patients (age 2 and above) being managed for Inflammatory Bowel Disease (IBD) in usual clinical practice. TARGET-IBD will create a research registry of patients with IBD within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.
Conditions
Timeline
- Start date
- 2017-07-24
- Primary completion
- 2027-03-01
- Completion
- 2027-03-01
- First posted
- 2017-08-16
- Last updated
- 2026-03-17
Locations
37 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03251118. Inclusion in this directory is not an endorsement.